Suppr超能文献

异基因骨髓移植后造血嵌合体与同种异体移植耐受的解离。

Dissociation of hemopoietic chimerism and allograft tolerance after allogeneic bone marrow transplantation.

作者信息

Umemura A, Morita H, Li X C, Tahan S, Monaco A P, Maki T

机构信息

Department of Surgery, Transplant Center, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.

出版信息

J Immunol. 2001 Sep 15;167(6):3043-8. doi: 10.4049/jimmunol.167.6.3043.

Abstract

Creation of stable hemopoietic chimerism has been considered to be a prerequisite for allograft tolerance after bone marrow transplantation (BMT). In this study, we demonstrated that allogeneic BMT with bone marrow cells (BMC) prepared from either knockout mice deficient in both CD4 and CD8 T cells or CD3E-transgenic mice lacking both T cells and NK cells maintained a high degree of chimerism, but failed to induce tolerance to donor-specific wild-type skin grafts. Lymphocytes from mice reconstituted with T cell-deficient BMC proliferated when they were injected into irradiated donor strain mice, whereas lymphocytes from mice reconstituted with wild-type BMC were unresponsive to donor alloantigens. Donor-specific allograft tolerance was restored when donor-type T cells were adoptively transferred to recipient mice given T cell-deficient BMC. These results show that donor T cell engraftment is required for induction of allograft tolerance, but not for creation of continuous hemopoietic chimerism after allogeneic BMT, and that a high degree of chimerism is not necessarily associated with specific allograft tolerance.

摘要

建立稳定的造血嵌合体被认为是骨髓移植(BMT)后同种异体移植耐受的先决条件。在本研究中,我们证明,用来自CD4和CD8 T细胞均缺陷的基因敲除小鼠或同时缺乏T细胞和NK细胞的CD3E转基因小鼠制备的骨髓细胞(BMC)进行同种异体BMT,可维持高度嵌合状态,但未能诱导对供体特异性野生型皮肤移植的耐受。用T细胞缺陷的BMC重建的小鼠的淋巴细胞在注入经照射的供体品系小鼠时会增殖,而用野生型BMC重建的小鼠的淋巴细胞对供体同种异体抗原无反应。当将供体型T细胞过继转移给接受T细胞缺陷BMC的受体小鼠时,可恢复供体特异性同种异体移植耐受。这些结果表明,诱导同种异体移植耐受需要供体T细胞植入,但同种异体BMT后建立持续的造血嵌合体则不需要,并且高度嵌合不一定与特异性同种异体移植耐受相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验